⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AXGN News
Axogen, Inc. Common Stock
Axogen Announces Proposed Public Offering of Common Stock
globenewswire.com
AXGN
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
globenewswire.com
AXGN
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
globenewswire.com
AXGN
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
globenewswire.com
AXGN
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
globenewswire.com
AXGN
Axogen, Inc. Reports Third Quarter 2025 Financial Results
globenewswire.com
AXGN
Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
globenewswire.com
AXGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
prnewswire.com
AXGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
prnewswire.com
AXGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
prnewswire.com
AXGN